Prescribing information

General prescribing guidance

• 28 Day Prescribing Policy March 17
• Anticholinergic, modfied, risk scale 2017
• Dressings Non Formulary Request form
• Drugs-driving Patient Information Leaflet July 2014
• Electronic Repeat Dispensing (eRD) Principles Sep 2017
• General Deprescribing Algorithm 2017
• Medication and falls risk classification guide 2017
• NICE TA Adherence Document Feb 2018
• Over the counter medicines for kidney patients
• Pain Management in Renal Failure Dec 2014
• Pain Management in Renal Failure-Quick Guide Dec 2014
• Pre-operative medication guidelines
• Prescriber and organisational changes
• Reminder Charts Prompt Sheets
• Renal patients with chronic kidney disease referral guidelines
• Self Care Policy Feb 2017
• Self Care Policy patient leaflet
• Self Care Q and A
• Situations not covered by the NHS Oct 17
• Tablet crushing guidelines for patients with swallowing difficulties May 2017
• Unlicensed medication treatment form
• Unlicensed Medicines and off licensed use, Statement of Good Practice Dec 2017

NEE prescribing formulary

• Continence formulary adult 2017
• Mental Health Formulary
• NEECCG Formulary March 2018
• Woundcare formulary Dec 2017

Shared prescribing guidance

• ADHD Continuing Care Full version
• ADHD NEP Continuing Care Summary
• Azathioprine/6-Mercatopurine in IBD
• Cinacalcet for the Treatment of Primary Hyperparathyroidism - July 2017
• Dementia Acetylcholinesterase (ache) inhibitors and memantine prescribing & treatment continuing care guidelines NEEMMC July 2016
• Denosumab-shared care
• Hydroxycarbamide
• Lithium therapy continuing care guidelines NEEMMC July 2016
• Long acting antipsychotics
• Melatonin Continuing Care Guidelines NEP March 2013
• Metolazone, treatment of Refractory Heart Failure Nov 2016
• Methotrexate Shared Care Dec 2017
• Mexilitine prescribing information Nov 2017
• Octreotide
• Rifamixin
• Teriparatide
• Ticagrelor for the treatment of ACS

Clinical Guidelines BNF Chapter 1 - Gastro-intestinal System

• Anal irrigation care pathway NEEMMC August 2016
• Colic in babies - information for parents Aug 2017 
• Constipation in adults - Guidelines for the management of NEEMMC July 2016
• Dyspepsia guidelines June 15
• Proton pump inhibitor deprescribing algoritum 2017

Clinical Guidelines BNF Chapter 2 - Cardiovascular System

• AF Anticoagulation - patient information
• Antiplatelet Guidelines for Cardiac patients with suspected GI bleed Jan 17
• Atrial fibrillation anticoagulation guidelines
• Bradycardia management in adults-treatment algorithm
• Heparin-induced Throbocytopenia, management of
• Hypertension guidelines for primary care - newly diagnosed May 17
• Management of adult patients on therapeutic anticoagulation who require elective surgery or an invasive procedure
• NOAC - counselling checklist
• NOAC-patient information
• Oral Anticoagulant Management Jan 17
• PE Dec 2017 pathway
• Ranolazine,Algorithm for use in Stable Angina
• Sacubitril/Valsartan Pathway (specialist initiation) 2017
• Suspected DVT LES Pathway Jan 2017 
• Use of Clopidogrel following an occlusive vascular event

Clinical Guidelines BNF Chapter 3 - Respiratory System

• Adult and Children over 12 Asthma Guidelines April 17
• Asthma guidelines management of chronic asthma in children aged 0-11years May 2017
• COPD Guidelines Sep 2017

Clinical Guidelines BNF Chapter 4 - Central Nervous System

• Antipsychotic use in Dementia
• Anxiety Disorders in Adults, Treatment of Guidelines
• Back pain pathway Oct 2017
• Back pain, Neuropathic pain and Non-cancer pain in adults guidelines Oct 2017
• Clozapine aide-memoire Feb 15
• Depression in Adults - Guidelines for the Treatment of
• Epilepsy guidelines
• Hypnotic and Benzodiazepine Policy (prescribing and withdrawal) April 2017
• Lidocaine patch proforma
• Nalmefene Pathway (Essex)
• Nalmefene Treatment Pathway and Referral Form Mar 15
• Neuropathic pain pathway Oct 2017
• Non-cancer chronic pain pathway Oct 2017
• Opioid treatment contract Sep 2017
• Pain Management in Opioid Dependent Patients
• Transdermal patch chart
• Trimipramine Withdrawal and Cross-Tapering
• Migraine Guidelines May 2017

Clinical Guidelines BNF Chapter 5 - Infections

• Administration of a cephalosporin to a patient with a penicillin allergy July 2017
• Anti-infective guidelines doses in renal failure and dialysis July 2017
• Antibiotics in primary care Oct 2017 guidelines
• Cephalosporins, Quinolones and Co-Amoxiclav Nov 2017 Primary care guidance
• Community Acquired Pneumonia CAP Antibiotic Guidelines July 2017
• Diabetic foot infections- Nov 2017 management guidelines
• Diagnosis and Management of UTI in community settings
• Suspected urinary tract infection (UTI) in adults ≥ 65 years old - Decision aid for diagnosis and management of Mar 2017 

Clinical Guidelines BNF Chapter 6 - Endocrine

• ABASAGLAR Initiating guidelines
• Bisphosphonates deprescribing guidelines 2017
• Blood glucose monitoring guidelines Sep 2017
• Hypoglycaemia management in adults July 17
• Insulin, Emergency Compatible Substitutions 
• Insulin guidelines for use in patients with Type 1 and Type 2 Diabetes
• Oral Hypoglycaemic Agents June 16
• Osteoporosis guidelines Feb 2018

Clinical Guidelines BNF Chapter 7 - Obs, Gynae and Urinary Tract

• Combined oral contraceptive guidelines
• HRT decision-making protocol NEEMMC July 2016
• Lower urinary tract symptoms in men management guidelines
• Penile Rehab-prescribing advice June 17
• Qlaira-guidelines for use
• Sildenafil generic-prescribing statement June 2017 
• Urinary incontinence in women Aug 16

Clinical Guidelines BNF Chapter 9 - Nutrition and Blood

• Erythropoietin-Travel guidance July 15
• Food first recipe book
• Hypophosphataemia management
• Infant formulae prescribing guidelines Jan 2018
• Oral nutritional supplements Jan 2018 guidelines
• Renavit prescribing in renal patients July 17
• Vitamin D guidelines

Clinical Guidelines BNF Chapter 10 - Musculoskeletal and Joint disorders

• Gout Treatment Pathway April 15

Clinical Guidelines BNF Chapter 11 - Eye

• Dry Eye aide memorie Feb 2018
• Dry Eye guidelines Dec 2017
• Glaucoma Treatment Algorithm Janruary 2017

Clinical Guidelines BNF Chapter 12 - Ear, nose and oropharynx

• Hypersalivation Guidelines-anticholinergic use

Clinical Guidelines BNF Chapter 13 - Skin

• Cellulitis management
• Emollient & corticosteroid Prescribing Guidelines Jan 2018
• Hyperhidrosis management July 15
• Hyperhidrosis, patient information leaflet
• Infantile Seborrhoeic Dermatitis Sep 2017
• Psoriasis of scalp – Adult Sep 2017
• Psoriasis Guidelines October 2010
• Seborrhoeic Dermatitis of the Scalp & Beard Sep 2017

Clinical Guidelines BNF Chapter 14 - Immunological products and vaccines

• Hep B Vacc schedule for pre-dialysis and dialysis patients
• Hep B Vacc Strategy for pre-dialysis and dialysis patients flow chart

Prescribing Policies

• Alimemazine Prescribing Policy Apr 2017
• Antihistamines Prescribing Policy Apr 2017
• Co-Proxamol no prescribing policy statement
• Camouflage Prescribing Policy Dec 2016
• Compression Hosiery Prescribing Policy Apr 2017
• Dental conditions supporting information to no prescribing policy statement
• Dental prescribing on fp10 no prescribing policy statement
• Dry eye drops no prescribing policy statement
• Eflornithine cream Vaniqa no prescribing policy statement
• Emollients, Soap Substitutes, Bath Oils or Shower Gels Prescribing Policy Jan 2018
• Flutter Device Prescribing Policy Jan 2018
• Freestyle Libre Prescribing Policy Sep 2017
• Hayfever Nasal and Eye Drops for the Treatment of Prescribing Policy Aug 2017
• Gluten Free Prescribing Policy Feb 2017
• Indigestion and Heartburn for Adults Prescribing Policy July 2017
• Infant Feed Prescribing Policy Jan 2018
• Infantile Colic on FP10 No Prescribing Policy Aug 2017
• Kerraped® or Similar Appliances, No Prescribing Policy July 2017
• Liothyronine to Levothyroxine Prescribing Policy and Guidance for Switching from unlicensed dried thyroid hormone extracts
• Lutein and oral antioxidant vitamins supplements No Prescribing Policy Aug 2017 
• Mebendazole Prescribing Policy Jan 2018
• Medicated Shampoos Prescribing Policy Jan 2018
• Melatonin for Insomnia Prescribing Policy Apr 2017
• Octenisan® MRSA Decolonisation advice Feb 2017
• Omega 3 fatty acids no prescribing policy statement
• PICC or Dialysis line covers Prescribing Policy July 2017
• Pigmanorm® Cream for Melasma no Prescribing Policy Nov 2016
• Probiotics VSL#3 or Similar Products Prescribing Policy August 2017
• Rubefacients Prescribing policy July 2017
• Safer Sharps Device Prescribing Policy Jan 2018
• Silicone Gels and Sheets Prescribing Policy Jan 2018
• Sip Feeds no prescribing policy statement
• Stoma Support Products Prescribing Policy Dec 2016
• Sunscreen prescribing policy July 2017
• Therapeutic Clothing (No Prescibing Policy)
• Thiamine Prescribing Policy March 2017
• Topical Haemoglobin (Granulox®) Spray no Prescribing Policy Dec 2016
• Thickening Agents for Infant Feeds Jan 2018
• Travel vaccines no prescribing policy statement
• Urea Cream and Spray for Cracked Heels no Prescribing Policy Dec 2016
• Vitamin B Prescribing Policy March 2017
• Vitamin D Prescribing Policy Jan 2018
• Vitamins and minerals no prescribing policy statement
• VSL#3® or Similar Products prescribing policy Aug 2017
• Waterproof Dressings and Cast Protectors Prescribing Policy Jan 2018